GlassScriptPhysician profile
Olivia S Johnson
NPI 1801454244
$3,534.33
in general payments reported to CMS, 2019-2025
34 companies · $1,651 in 2025
The $1,651 reported for 2025 was more than what 93% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $344 · 2024: $1,539 · 2025: $1,651.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,349 · Education: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,349.38 |
| Education | $184.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $406.35 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $369.73 | 2023-2025 | Airsupra, Breztri, Farxiga |
| Pfizer INC. | $297.23 | 2023-2025 | |
| Novo Nordisk INC | $289.10 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Amgen INC. | $275.21 | 2024-2025 | Repatha, Otezla, Otezla |
| Corcept Therapeutics | $210.20 | 2024-2025 | Korlym |
| Lilly USA, LLC | $204.30 | 2024-2025 | Zepbound, Mounjaro, Jardiance |
| Astellas Pharma US INC | $198.76 | 2023-2025 | Veozah |
| Sumitomo Pharma America, INC. | $142.14 | 2023-2025 | Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $132.28 | 2024-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $115.40 | 2023-2025 | Xifaxan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $87.32 | 2024 | Jardiance |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $86.94 | 2025 | Caplyta |
| Xeris Pharmaceuticals, INC. | $81.52 | 2025 | Keveyis, Gvoke Hypopen |
| Otsuka America Pharmaceutical, INC. | $80.68 | 2025 | Rexulti |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $63.67 | 2024-2025 | Gardasil 9, Vaxneuvance, Capvaxive |
| Axsome Therapeutics, INC. | $55.22 | 2023-2025 | Symbravo, Sunosi |
| Medtronic, INC. | $47.09 | 2024 | Intellis Adaptivestim |
| Tolmar, INC. | $37.21 | 2025 | Jatenzo |
| Glaxosmithkline, LLC. | $36.48 | 2024-2025 | Arexvy, Shingrix |
| Exact Sciences Corporation | $34.56 | 2023-2024 | Cologuard Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $34.37 | 2024-2025 | Gattex, Trintellix |
| Irhythm Technologies, INC. | $31.07 | 2024 | Zio Xt Patch, Zio Monitor |
| Idorsia Pharmaceuticals US INC | $28.00 | 2023-2024 | Quviviq |
| Lundbeck LLC | $24.35 | 2025 | Rexulti |
| Scilex Pharmaceuticals INC. | $23.64 | 2024 | |
| Tandem Diabetes Care, INC. | $21.46 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Insulet Corporation | $20.23 | 2025 | Omnipod |
| Radius Health, INC. | $19.16 | 2025 | Tymlos |
| Sonex Health, INC. | $18.97 | 2024 | Sx-One Microknife |
| Dexcom, INC. | $17.66 | 2024 | Dexcom G6 Transmitter |
| Verity Pharmaceuticals INC. | $16.74 | 2024 | Tlando |
| Janssen Pharmaceuticals, INC | $15.23 | 2024 | Xarelto |
| Phathom Pharmaceuticals, INC. | $12.06 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olivia Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.